What Is DSIP?

Overview

DSIP, or Delta Sleep-Inducing Peptide, is a naturally occurring nonapeptide — a chain of nine amino acids with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was first isolated decades ago from the cerebral venous blood of rabbits during slow-wave (delta) sleep, which is how it earned its name. In research it is treated as a neuromodulator rather than a classical hormone, and it is studied less for a single defined action than for the cluster of sleep, endocrine and stress-related effects that older neurology work attributed to it.

How DSIP Works

The molecular target of DSIP has never been fully pinned down, and the literature is candid that no single receptor accounts for every reported effect. What the data do suggest is that the peptide can cross the blood-brain barrier and influence central sleep-wake signalling, with EEG studies in animals linking it to greater delta-wave activity. Separately, it has been examined for its apparent dampening of the hypothalamic-pituitary-adrenal axis — blunting ACTH and corticosterone responses in animal stress models — which is why much of the work frames it as a bridge between sleep regulation and stress biology rather than a pure sedative.

What the Research Explores

• Slow-wave (delta) sleep architecture and sleep-onset dynamics in EEG models.
• Hypothalamic-pituitary-adrenal modulation and the stress-response axis.
• Neuroendocrine signalling involving cortisol, growth hormone and pituitary pathways.
• Pain physiology and observations reported in opioid-withdrawal contexts.

Forms & Handling

DSIP is typically supplied as a lyophilized powder in vials sized for microgram-scale research, commonly 10 mg. For laboratory work it is reconstituted with bacteriostatic or sterile water — a 10 mg vial in 3.0 mL of diluent yields roughly 3.33 mg/mL — and kept refrigerated once in solution, with the sealed powder stored frozen. Because it is studied at microgram quantities, a larger diluent volume is used to keep the small draws readable on an insulin syringe. See the dosing protocol below for the full reconstitution math expressed in insulin-syringe units.

Safety & Research Notes

DSIP is an investigational research compound with no approved human or veterinary use and no established clinical safety profile. The available evidence comes largely from older European neurology and biobehavioural studies, and reported tolerability — including a notably wide margin in animal work — should not be read as a usage endorsement. Everything described here is mechanistic background for laboratory reference, not a recommendation.

References

Related Protocols